Loading company…
Vienna-based biopharmaceutical company developing therapeutics for viral diseases and immune disorders, founded in 2006.
Marinomed Biotech AG, founded in 2006 and based in Vienna, Austria, develops therapeutics for viral infectious diseases and autoimmune disorders, including Budesolv, Tacrosolv and Satiasolv. Its products are aimed at healthcare providers, hospitals and pharmacies, mainly in Austria and Switzerland. In fiscal 2021 it reported revenue of EUR 13,791,684.50 and EBITDA of EUR -5,617,951.70. Invest AG invested in the company on March 21, 2016.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in